← Eichor
Study identifier: NCT06031025 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Prevalence and Natural History of Functional Gastrointestinal Disorders Among At-risk Infants.

Condition: Functional Gastrointestinal Disorders · Gastroesophageal Reflux · Constipation - Functional  ·  Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

PhaseN/A
Planned participants71
Who can joinAll sexes, 3 Months to 24 Months
Healthy volunteersNo

About this study

The goal of this observational study is to learn about the prevalence and characteristics of functional gastrointestinal disorders (FGID) in at risk infants (former preterm infants and those with birth asphyxia) during the first 2 years of life. The main questions it aims to answer are: * evaluate the prevalence of symptoms related to gastro-esophageal reflux (GER), of functional gastrointestinal disorders during the first 2 years of life * describe growth parameters during follow-up up to the corrected age of 2 years Participants will be assessed clinically and with a structured questionnaire based on the Rome IV criteria to describe FGID.

This description comes directly from the study's public registry record.

Talk to the study team

Stefano Nobile, MD, PhD, MSc  ·  +390630156937  ·  stefano.nobile@policlinicogemelli.it

Always discuss trial participation with your own doctor first.

Locations (1)

Fondazione Policlinico Gemelli IRCCSRoma, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06031025